Chemed (CHE) came out with quarterly earnings of $4.27 per share, missing the Zacks Consensus Estimate of $4.78 per share. This compares to earnings of $5.47 per share a year ago. These figures are adjusted for non- recurring items. Chemed, which belongs to the Zacks Medical - Outpatient and Home Healthcare industry, posted revenues of $618.8 million for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 0.45%. This compares to year-ago revenues of $595.88 million. The company has toppe ...